Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.04 USD | -1.16% | -1.40% | -14.02% |
03:25pm | Everlasting momentum | |
12:49pm | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.02% | 90.31B | |
+33.48% | 709B | |
+30.67% | 595B | |
-2.28% | 367B | |
+20.34% | 334B | |
+4.88% | 289B | |
+14.32% | 239B | |
+9.26% | 211B | |
-3.72% | 203B | |
+8.68% | 171B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Morgan Stanley Trims Price Target on Bristol-Myers Squibb to $41 From $42, Incorporates Mirati Transaction Into Model; Underweight Kept